Kendall Au
Stock Analyst at RBC Capital
(3.15)
# 2,567
Out of 5,128 analysts
53
Total ratings
61.3%
Success rate
6.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kendall Au
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Reiterated: Hold | $190 → $225 | $215.71 | +4.31% | 5 | Nov 5, 2026 | |
| EW Edwards Lifesciences | Reiterated: Buy | $110 → $115 | $105.80 | +8.70% | 4 | Nov 5, 2026 | |
| GMED Globus Medical | Reiterated: Buy | $85 | $72.30 | +17.57% | 3 | Nov 5, 2026 | |
| TFX Teleflex | Reiterated: Buy | $155 → $175 | $153.15 | +14.27% | 3 | Nov 5, 2026 | |
| TNDM Tandem Diabetes Care | Reiterated: Buy | $26 | $17.51 | +48.49% | 3 | Nov 5, 2026 | |
| OM Outset Medical | Reiterated: Hold | $7 | $3.86 | +81.35% | 3 | Nov 4, 2026 | |
| PODD Insulet | Reiterated: Buy | $160 → $180 | $149.29 | +20.57% | 3 | Nov 4, 2026 | |
| ZBH Zimmer Biomet Holdings | Reiterated: Buy | $110 → $125 | $104.56 | +19.55% | 3 | Nov 4, 2026 | |
| INSP Inspire Medical Systems | Reiterated: Hold | $75 | $60.54 | +23.89% | 3 | Nov 2, 2026 | |
| PEN Penumbra | Reiterated: Hold | $374 | $320.77 | +16.59% | 3 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 | $81.39 | +29.01% | 3 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $420 → $375 | $312.39 | +20.04% | 4 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $52 | $44.20 | +17.65% | 3 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $90 | $81.84 | +9.97% | 4 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 → $125 | $107.25 | +16.55% | 2 | Oct 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $575 → $550 | $439.89 | +25.03% | 2 | Oct 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $118 | $100.99 | +16.84% | 2 | Oct 1, 2026 |
Becton, Dickinson and Company
Nov 5, 2026
Reiterated: Hold
Price Target: $190 → $225
Current: $215.71
Upside: +4.31%
Edwards Lifesciences
Nov 5, 2026
Reiterated: Buy
Price Target: $110 → $115
Current: $105.80
Upside: +8.70%
Globus Medical
Nov 5, 2026
Reiterated: Buy
Price Target: $85
Current: $72.30
Upside: +17.57%
Teleflex
Nov 5, 2026
Reiterated: Buy
Price Target: $155 → $175
Current: $153.15
Upside: +14.27%
Tandem Diabetes Care
Nov 5, 2026
Reiterated: Buy
Price Target: $26
Current: $17.51
Upside: +48.49%
Outset Medical
Nov 4, 2026
Reiterated: Hold
Price Target: $7
Current: $3.86
Upside: +81.35%
Insulet
Nov 4, 2026
Reiterated: Buy
Price Target: $160 → $180
Current: $149.29
Upside: +20.57%
Zimmer Biomet Holdings
Nov 4, 2026
Reiterated: Buy
Price Target: $110 → $125
Current: $104.56
Upside: +19.55%
Inspire Medical Systems
Nov 2, 2026
Reiterated: Hold
Price Target: $75
Current: $60.54
Upside: +23.89%
Penumbra
Oct 30, 2026
Reiterated: Hold
Price Target: $374
Current: $320.77
Upside: +16.59%
Oct 29, 2026
Reiterated: Buy
Price Target: $105
Current: $81.39
Upside: +29.01%
Oct 29, 2026
Rated: Buy
Price Target: $420 → $375
Current: $312.39
Upside: +20.04%
Oct 28, 2026
Reiterated: Buy
Price Target: $70 → $52
Current: $44.20
Upside: +17.65%
Oct 28, 2026
Reiterated: Buy
Price Target: $80 → $90
Current: $81.84
Upside: +9.97%
Oct 21, 2026
Reiterated: Buy
Price Target: $130 → $125
Current: $107.25
Upside: +16.55%
Oct 20, 2026
Reiterated: Buy
Price Target: $575 → $550
Current: $439.89
Upside: +25.03%
Oct 1, 2026
Reiterated: Buy
Price Target: $118
Current: $100.99
Upside: +16.84%